share_log

威尔药业关于向不特定对象发行可转换公司债券申请文件的第二轮审核问询函回复(修订稿)的提示性公告

Weil Pharmaceutical\'s indicative announcement on the response to the second round of review inquiry letters (revised draft) on the issuance of convertible corporate bonds to unspecified targets

SZSI ·  Jan 24, 2024 00:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more